Feedback / Questions
HyBryte (synthetic hypericin) - Soligenix
https://www.prnewswire.com/news-releases/soligenix-achieves-enrollment-milestone-for-planned-interim-analysis-in-confirmatory-phase-3-clinical-trial-of-hybryte-for-the-treatment-of-cutaneous-t-cell-lymphoma-302619926.html
Nov 19, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next